Francine Garrett-Bakelman

Garrett-Bakelman, Francine

Primary Appointment

Assistant Professor, Biochemistry and Molecular Genetics


  • Clinical Fellowship, Hematology and Medical Oncology, Weill Cornell Medical College
  • Postdoc, Postdoctoral training in epigenomics & hematological malignancies experimentation, Weill Cornell Medical College
  • BS, Biochemistry and Cell Biology, California State University, Fullerton
  • MD/PhD, Medicine and Cell Biology, Albert Einstein College of Medicine

Contact Information

LAB :PO Box 800733, 1340 JPA Pinn Hall Rm 6054A
UVA Cancer Ctr Clinic: PO Box 800334
Charlottesville, Virginia 22908
Telephone: Office: 434-924-9220 (no patient-related calls accepted); Clinical practice: 434-924-9333
Fax: Office: 434-924-5069 (no patient-related information accepted); Clinical practice: 434-244-7526
Email: (For patients: if you are in need of assistance, please call clinical practice)

Research Disciplines

Bioinformatics and Genomics, Cancer Biology, Epigenetics, Molecular Biology, Translational Science

Research Interests

Acute Myeloid Leukemia: molecular and cellular biology events which mediate aberrant epigenetic and transcriptional mechanisms during disease establishment and progression

Research Description

Acute Myeloid Leukemia (AML) is the most common acute leukemia in adults. AML prognosis and overall survival decline in patients older that 60 years of age and in patients who develop disease relapse after initial treatments. Our main research goal is to understand molecular and epigenetic mechanisms responsible for AML disease phenotypes. Through this aim, in the long-term, findings will help identify novel therapeutic targets in AML.

We investigate these questions through the study of samples from AML patients and functional validations in in vitro and in vivo models. Epigenetic (DNA methylation, gene expression, and chromatin assays), molecular and cellular biology techniques are implemented to study how aberrant expression of specific genes contributes to abnormal cellular phenotypes and leukemogenesis. Previous studies have determined that AML progression (from disease diagnosis to relapse) is characterized by significant epigenetic plasticity and differentially expressed genes. Studies are being pursued to identify genes affected by the epigenetic changes observed and how their function contributes to the malignant phenotype.

Complete List of Published Work in MyBibliography:

Selected Publications